Main Article Content


The extended-spectrum b-lactamase (ESBL) producer bacteria until now were mostly identified in hospital environment. The aim of this study was to analyze the prevalence of ESBL-producing gut flora and distribution of ESBL encoding genes between hospitalized patient in Tropical Wards of Dr. Soetomo Hospital and patient from a primary health centre (PHC) as community environment in Surabaya. Thiry rectal swab samples from hospital of Dr. Soetomo patients and from PHC (60 samples in total) were collected for this study. Samples were screened in MacConkey agar supplemented with 2 mg/L of cefotaxim, incubated at 37ºC for 24 hours. Then the growing colony were confirmed with Disk Diffusion Synergy test (DDST) for diagnosis of ESBL producer. The identified ESBL producers were then identified the bacteria species by biochemical method. ESBL gene were detected by PCR with specific primers. The results showed that there was not difference of positif nuber of ESBL-producing bacteria gut floral between patients of Dr.Soetomo Hospital, 25/30 (83.3%) and PHC, 11/30 (36.7%) (p=1). The pattern of ESBL gene distributions among samples from hospital showed that SHV was 12%, TEM was 36%, and CTX-M was 80%, and from PHC were SHV 18.2%, TEM 27,3% and CTX-M 81,8%. Statistical analysis showed that the pattern was not significantly different among hospitals and PHC samples as shown by SHV gene (p=0,631), TEM (p= 0.715), and CTX -M (p=1). From each ESBL gene, the dominant genes that found producing ESBL were the CTX-M genes followed by TEM and SHV genes. The prevalence of ESBL producersin intestinal flora of both the hospital (83,3%) and the PHC (36,7%) was very high. There was not significant difference between the prevalence of ESBL producer in gut flora of hospitalized patients compared to PHC. There was found other patterns of ESBL gene combinations in the hospital of SHV+CTX-M genes, TEM+CTX-M, SHV+TEM+CTX-M genes and PHC, the combination pattern of SHV+CTX-M, TEM+CTX-M.


Gut flora ESBL Dr. Soetomo Hospital Primary Health Centre (PHC)

Article Details

How to Cite
Naelasari, D. N., Koendhori, E. B., Dewanti, L., Sarassari, R., & Kuntaman, K. (2018). The Prevalence of Extended Spectrum Beta-Lactamase (ESBL) Producing Gut Bacterial Flora Among Patients in Dr. Soetomo Hospital and Primary Health Centre in Surabaya. Folia Medica Indonesiana, 54(4), 256–262.


  1. Amaya E, Reyes D, Paniagua M, Calderon S, Rashid MU, Colque P, Kuhn I, Mollby R, Weintraub A, Nord CE. 2012. Antibiotic resistance patterns of Escherichia coli isolates from different aquatic environmental sources in Leon, Nicaragua. Clin. Microbiol. Infect. 18:E347-E354.
  2. Amrin. 2001. Antimicrobial resistance in Indonesia : Prevalance and prevention. The Collaboration research Indonesia and The Netherlands. Not yet published.
  3. Bonnet R. 2014. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother.48 (1). pp:1-14
  4. Biswas SM, Ara N, Huda N, Andalib S, Rahman M H, Mia MRA. 2015. Detection and Antimicrobial Susceptibility Pattern of Extended Spectrum Beta Lactamases (ESBLs) Producing Gram Negative Bacteria from Different Clinical Samples. Pulse Volume 8. PP: 15-20.
  5. Carattoli A. 2009. Resistance plasmid families in Enterobacteriaceae. Antimicrob Agents Chemother. 53:2227-2238.
  6. Chong, Y., Shimoda, S., et al. 2013. Community spread of extended-spectrum beta-lactamase-producing Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis: A long-term study in Japan. Journal of Medical Microbiology, 62(PART7), pp. 1038-1043. doi: 10.1099/jmm.0.059279-0.
  7. Colodner, R, Raz R. 2005. Extended-Spectrum Beta-Lactamase : The End of Cephalosporins : IMAJ ; 7 : PP 336-8
  8. Dalela G. 2012. Prevalence of extended spectrum beta-lactamase (ESBL) producers among gram-negative bacilli from various clinical isolates in a tertiary care hospital at Jhalawar, Rajasthan, India. J ClinDiag Research. 6(2):182-187
  9. Dewanti L, Sulistiawati, M. Qiptiah , U Hadi, H. Paraton, K. Kuntaman. 2016. Survey Penggunaan Antibiotik dan Mikroba Resistensi di Puskesmas di Surabaya. Survey Oleh Direktorat Jenderal Pelayanan Kesehatan Kementerian Kesehatan Republik Indonesia. Unpublished.
  10. Dhara M, Disha P, Sachin P, Manisha J, Seema B, Vegad MM. 2012. Comparison of various methods for the detection of extended spectrum beta-lactamases in Klebsiella pneumoniae isolated from neonatal intensive care unit. National J Med Res. 2012; 2: 348-53.
  11. Ferreira Cristina Motta, William Antunes Ferreira, Nayanne Cristina Oliveira da Silva Almeida, Felipe Gomes Naveca, Maria das Graças Vale Barbosa. 2011. Extended spectrum beta lactamase producing bacteri isolated from hematologic patients in manaus, state of Amazonas, Brazil. Brazilian Journal of Microbiology. 42: 1076-1084
  12. Guimaraes B, Barreto A, Radhouani H, Figueiredo N, Gaspar E, Rodrigues J, Torres C, Igrejas G, Poeta P. 2009. Genetic detection of extended-spectrum beta-lactamase-containing Escherichia coli isolates and vancomycin-resistant enterococci in fecal samples of healthy children. Microb Drug Resist, 15(3):211-216.
  13. Hawkey PM. Prevalence and clonality of extended-spectrum b-lactamases in Asia. Clin Microbiol Infect 2008; 14 Suppl 1. pp: 159-65.
  14. Hilty, M., Betsch, B. Y., Bögli-Stuber, et al (2012) ‘Transmission dynamics of
  15. extended-spectrum -lactamase-producing enterobacteriaceae in the tertiary care
  16. hospital and the household setting’, Clinical Infectious Diseases, 55 (7), pp.
  17. -975. doi: 10.1093/cid/cis581.
  18. Imasari, T., Wiwik T., Wasito, E.B. K.Kuntaman. 2017. The Prevalence and Patterns of Gene Among Bacterial Gut Flora of Dairy Cows And People Around Farm In Surabaya. Journal Veteriner Udayana.
  19. Jarlier V, Nicolas MH, Fournier G, Philippon A. 1988. Extended broad-spectrum beta lactamases conferring transferable resistance to newer beta lactam agents in Enterobacteriaceae: hospital prevalance and susceptibility patterns. Rev. Infect. Dis. 10: 867-878.
  20. Jernberg C, Lo¨ fmark S, Edlund C, and Jansson J K. 2010. Long-term impacts of antibiotic exposure on the human intestinal microbiota. Mini-Review Microbiology Journals 156, pp. 3216-3223
  21. Kluytmans JA, Overdevest IT, Willemsen I, Kluytmans-van den Bergh MF, van der Zwaluw K, Heck M, Rijnsburger M, Vandenbroucke-Grauls CM, Savelkoul PH, Johnston BD, Gordon D, Johnson JR. 2013. Extended-spectrum beta-lactamase-producing Escherichia coli from re-tail chicken meat and humans: comparison of strains, plasmids, resis-tance genes, and virulence factors. Clin. Infect. Dis. 56:478 - 487.
  22. Kumar, AV & Babuz R.2013. Fecal Carriage of Extended-Spectrum beta-lactamase producing Enterobacteriaceae. J. Medical Microbiology & Diagnosis, 2:3.
  23. Kuntaman, K., Hadi, U., et al. 2016. Prevalence of Methicillin Resistant Staphylococcus Aureus From Nose and Throat of Patients on Admission To Medical Wards of Dr Soetomo Hospital, Surabaya, Indonesia. The Southeast Asian journal of tropical medicine and public health, 47(1), pp. 66-70.
  24. Luvsansharav UO, Hirai I, Nakata A, Imura K, Yamauchi K, Niki M, Komalamisra C, Kusolsuk T, and Yamamoto Y. 2012. Prevalence of and risk factors associated with faecal carriage of CTX-M b-lactamase-producing Enterobacteriaceae in rural Thai communities. J Antimicrob Chemother. Japan; 67. pp: 1769 -1774
  25. Moustafa S H, Anwar M F, Moustafa F A, Hussein K A. 2015. Multidrug-resistant ESBL-producing Enterobacteriaceae and associated risk factors in community infants in Lebanon. J Infect Dev Ctries. pp:947-955.
  26. Peterson, D.L & Bonomo, R.A. 2005. Extended Spectrum Beta-Lactamases : a Clinical update. J. Clinical Microbiology Reviews Oct 2005. American Society for Microbiology. Vol.18,No.4. pp.657-686
  27. Pitout Johan D & Kevin B Laupland, 2008. Extended-spectrum beta-lactamase-producing Enterobacteriaceae : an emerging public-healt concern. Lancet Infect Dis, 8: pp 159-161.
  28. Poirel L, Nordmann P, Ducroz S, Boulouis HJ, Arne P, Millemann Y. 2013. Extended-spectrum beta-lactamase CTX-M-15-producing Kleb-siella pneumoniae of sequence type ST274 in companion animals. Anti-microb. Agents Chemother. 57:2372-2375
  29. Rao S. 2012. CTX-M beta-lactamases. [Internet]. [diunduh 2017Feb22]. Tersedia pada:
  30. Rakotonirina H C, Garin B, Randrianirina F, Vincent R, Talarmin A, and Guillaume A. 2013. Molecular characterization of multidrug-resistant extended-spectrum beta-lactamase-producing Enterobacteriaceae isolated in Antananarivo, Madagascar. BMC Microbiologi. pp: 13-85.
  31. Rossolini G M, D’Andrea M M, and C. Mugnaioli. 2008. The spread of CTX-M-type extended-spectrum b-lactamases. Journal complication. European Society of Clinical Microbiology and Infectious Diseases, CMI, 14 (Suppl. 1), pp:33-41
  32. Sasaki T, Hirai I, Niki M, Nakamura Tatsuya, Komalamisra C, Maipanich W, Kusolsuk T, Sa-nguankiat S, Pubampen S, and Yamamoto Y. 2010. High prevalence of CTX-M b—lactamase-producing Enterobacteriaceae in stool specimens obtained from healthy individuals in Thailand. J. Antimicrob Chemother.65: pp 666-668.
  33. Sarassari R. 2017. Tesis. Perbandingan Pola Fenotipik Dan Genotipik Bakteri Penghasil ESBL Dari Flora Usus Pasien Di ICU, Rawat Inap Tropik Infeksi, Dan Populasi Di Komunitas. FK. Unair. Unpublished.
  34. Severin, J.A. 2010. Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumonia isolates from Surabaya, Indonesia,. J. Antimicrob Chemother, 65, pp. 465-469.
  35. Shakil S & Khan AU. 2010. Infected foot ulcers in male and female diabetic patients: a clinico-bioinformative study. Licensee BioMed Central Ltd. India; Aligarh Muslim University.
  36. Tille, Patricia M. 2014. Bailey & Scott’s Diagnostic Microbiology. 13th. Mosby, Inc., an affiliate of Elsevier Inc. Riverport Lane St. Louis, Missouri 63043.
  37. Woerther P L, Burdet Charles, Elisabeth Chachaty, Antoine Andremont. 2013. Trends in Human Fecal Carriage of Extended-Spectrum -Lactamases in the Community: Toward the Globalization of CTX-M. Clinical Microbiology Reviews. pp. 744-758

Most read articles by the same author(s)